An Junsha, Chen Pingting, Li Xin, Li Xiuchuan, Peng Fu
Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu, 610041, China.
Department of cardiology, General Hospital of Western Theater Command, Chengdu, 610083, China.
Transl Oncol. 2024 Jul;45:101964. doi: 10.1016/j.tranon.2024.101964. Epub 2024 Apr 23.
Although there is evidence of the association between RA and NSCLC, little is known about their interaction mechanisms. The aim of this study is to identify potential hub genes and biological mechanism in RA and NSCLC via integrated bioinformatics analysis.
The gene expression datasets of RA and NSCLC were downloaded to discover and validate hub genes. After identifying DEGs, we performed enrichment analysis, PPI network construction and module analysis, selection and validation of hub genes. Moreover, we selected the hub gene PTPRC for expression and prognosis analysis, immune analysis, mutation and methylation analysis in NSCLC. Finally, we performed real-time PCR, colony formation assay, wound healing assay, transwell invasion assay, sphere formation assay and western blotting to validate the role of PTPRC in A549 cells.
We obtained 320 DEGs for subsequent analysis. Enrichment results showed that the DEGs were mainly involved in Th1, Th2 and Th17 cell differentiation. In addition, four hub genes, BIRC5, PTPRC, PLEK, and FYN, were identified after selection and validation. These hub genes were subsequently shown to be closely associated with immune cells and related pathways. In NSCLC, PTPRC was downregulated, positively correlated with immune infiltration and immune cells. Experiments showed that PTPRC could promote the proliferation, migration and invasion, and the ability to form spheroids of A549 cells. In addition, PTPRC could regulate the increased expression of CD45, β-catenin, c-Myc and LEF1 proteins.
This study explored the hub genes and related mechanisms of RA and NSCLC, demonstrated the central role of the inflammatory response and the adaptive immune system, and identified PTPRC as an immune-related biomarker and potential therapeutic target for RA and NSCLC patients. In addition, PTPRC can significantly promote the proliferation, migration and invasion of A549 cells, and its mechanism may be to promote the EMT process by regulating the Wnt signaling pathway and promote cell stemness, which in turn has a promoting effect on A549 cells.
尽管有证据表明类风湿关节炎(RA)与非小细胞肺癌(NSCLC)之间存在关联,但其相互作用机制仍知之甚少。本研究旨在通过综合生物信息学分析确定RA和NSCLC中的潜在枢纽基因及生物学机制。
下载RA和NSCLC的基因表达数据集以发现和验证枢纽基因。在鉴定出差异表达基因(DEGs)后,我们进行了富集分析、蛋白质-蛋白质相互作用(PPI)网络构建及模块分析、枢纽基因的筛选与验证。此外,我们选择枢纽基因PTPRC进行NSCLC中的表达及预后分析、免疫分析、突变和甲基化分析。最后,我们进行实时定量聚合酶链反应(PCR)、集落形成实验、伤口愈合实验、Transwell侵袭实验、球体形成实验及蛋白质免疫印迹法以验证PTPRC在A549细胞中的作用。
我们获得了320个DEGs用于后续分析。富集结果表明,DEGs主要参与Th1、Th2和Th17细胞分化。此外,经过筛选和验证,确定了四个枢纽基因,即BIRC5、PTPRC、PLEK和FYN。这些枢纽基因随后被证明与免疫细胞及相关通路密切相关。在NSCLC中,PTPRC表达下调,与免疫浸润和免疫细胞呈正相关。实验表明,PTPRC可促进A549细胞的增殖、迁移和侵袭以及球体形成能力。此外,PTPRC可调节CD45、β-连环蛋白、c-Myc和LEF1蛋白表达增加。
本研究探索了RA和NSCLC的枢纽基因及相关机制,证明了炎症反应和适应性免疫系统的核心作用,并确定PTPRC为RA和NSCLC患者的免疫相关生物标志物及潜在治疗靶点。此外,PTPRC可显著促进A549细胞的增殖、迁移和侵袭,其机制可能是通过调节Wnt信号通路促进上皮-间质转化(EMT)过程并促进细胞干性,进而对A549细胞产生促进作用。